Equillium | Investor Presentation Deck | 39 slides · page 20 of 39
Includes comparative data against Mogamulizumab (MAVORIC trial) and visual evidence of skin improvement.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 image 1/1 list 1/1 source-note 1/1 table 1/1 title 1/1
Components 6
primary photo bullet source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1